Milestone Pharmaceuticals Inc. (MIST) — Operating Income

Annual figures by fiscal year, from SEC filings.

2018: -$23.82M2019: -$57.88M2020: -$50.71M2021: -$43.07M2022: -$59.64M2023: -$61.10M2024: -$42.10M2025: -$62.14M-$62.14M
2018Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$62.14M-47.6%
2024-$42.10M+31.1%
2023-$61.10M-2.4%
2022-$59.64M-38.5%
2021-$43.07M+15.1%
2020-$50.71M+12.4%
2019-$57.88M-143.0%
2018-$23.82M